Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03502577
Title BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
Recruitment Suspended
Gender
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

multiple myeloma

Therapies

Anti-BCMA CAR T Cells + Cyclophosphamide + Fludarabine + LY3039478

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.